DOYLESTOWN, Pa.--(BUSINESS WIRE)--Marcum LLP and Philadelphia SmartCEO recognized the area’s top leaders in innovation at the 2014 Marcum Innovator of the Year Awards, which took place on October 22, 2014 at the Cescaphe Ballroom in Philadelphia, PA. The 2014 finalists and winners were also profiled in the September/October issue of Philadelphia Smart CEO Magazine. Renold Capocasale, CEO and Founder of FlowMetric, Inc., was recognized as a Marcum Innovator of the Year for the Med-sized Biotech/Healthcare category.
The Marcum Innovator of the Year Awards honor innovators in their fields who have developed products, practices and services that improve quality of life and business practices. “The Marcum Innovator of the Year finalists have shaped the Philadelphia business community in ways that have not gone unnoticed. They are distinguished leaders in their fields and have demonstrated incredible innovation,” says Rick Crane, Regional President of SmartCEO media. “We are proud to recognize them for their achievements and excellence. They have set the bar high for their industries and the rest of the world.”
After spending over a decade as a scientist for Centocor (A Johnson & Johnson Company), a layoff in late 2009 motivated Renold Capocasale to found his own business to provide flow cytometry services to biotechnology and pharmaceutical companies. Almost five years later, FlowMetric, Inc is now recognized as a successful niche CRO providing flow cytometry services globally. Capocasale’s analyses helped launch two marketed drugs while at Centocor, Stelara and Remicade, and earned five Johnson & Johnson awards for scientific excellence and innovation. “Being recognized as a Marcum Innovator of the Year is very humbling and is true sentiment for my team’s uncompromising efforts at FlowMetric. Without their consistent support and unwavering engagement this all would not have been possible,” says Capocasale.
About FlowMetric
FlowMetric, Inc., is a niche contract research organization (CRO), focused on providing polychromatic flow cytometry and cell sorting services to bio-pharma and drug discovery companies. FlowMetric is committed to providing independent, unbiased, comprehensive and precise test services as part of the pre-clinical and clinical trial process for its clients. FlowMetric offers integrated, cost-effective, and specialized polychromatic flow cytometry services delivered with an uncompromising commitment to quality. For more information, visit www.flowmetric.com.
